A case of Satoyoshi syndrome with symptoms resembling neuroleptic malignant syndrome

Clinical Neurology

Volumn 38, Issue 7, 1998, Pages 637-640

  Adachi, Hiroaki ^a,b   Riku, Shigeo ^a   Fujishiro, Ken Ichiro ^a   Kuru, Satoshi ^b  

^a CHUKYO HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Malignant hyperthermia; Midazolam; Neuroleptic malignant syndrome; Satoyoshi syndrome

Indexed keywords

MIDAZOLAM; PREDNISONE; STEROID;

ACUTE KIDNEY FAILURE; ADULT; ALOPECIA; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMA; DIARRHEA; FEVER; HUMAN; HYPERTHERMIA; HYPOTENSION; INSOMNIA; MALE; MULTIPLE ORGAN FAILURE; MUSCLE SPASM; NEUROLEPTIC MALIGNANT SYNDROME; NEUROLOGIC DISEASE; RHABDOMYOLYSIS; SATOYOSHI SYNDROME; SKELETON MALFORMATION;

ADULT; ANTI-ANXIETY AGENTS; HUMANS; MALE; MIDAZOLAM; MUSCLE SPASTICITY; NEUROLEPTIC MALIGNANT SYNDROME;

EID: 0031797392     PISSN: 0009918X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Satoyoshi E, Yamada K : Two unusual cases of muscle cramps and multiple bony abnormalities. Proceeding of the First Pan American Congress of Neurology, 1963, pp 880-885
2. Satoyoshi E, Yamada K : Recurrent muscle spasms of central origin - a report of two cases. Arch Neurol 16 : 254-264, 1967
3. Ikegawa S, Nagano A, Nakamura K, et al : A case of Satoyoshi's syndrome. J Pediatr Orthop 13 : 793-796, 1993
4. Ehlayel MS, Lacassie Y : Satoyoshi syndrome : an unusual postnatal multisystemic disorder. Am J Med Genet 57 : 620-625, 1995
5. Arita J, Hamano S, Nara T, et al. Intravenous gammaglobulin therapy of Satoyoshi syndrome. Brain Dev 18 : 409-411, 1996
6. Merello M, García H, Nogués M, et al : Masticatory muscle spasm in a non-Japanease patient with Satoyoshi syndrome successfully treated with botulinum toxin. Mov Disord 9 : 104-105, 1994
7. Wang D. Fu H : Three cases of recurrent generalized muscle spasms in China. Jap J Med 24 263-268, 1985
8. Toru M, Matsuda O, Makiguchi K, et al : Neuroleptic malignant syndrome-like state following a withdrawal of antiparkinsonian drugs. J Nerv Ment Dis 169 : 324-327, 1981
9. Schibuk M, Schachter D : A role for catecholamines in the pathogenesis of neuroleptic malignant syndrome. Can J Psychiatry 31 : 66-69, 1986
10. MacLennan DH, Phillips MS: Malignant hyperthermia. Science 256 : 789-794, 1992
11. Miyatake R, Iwahashi K, Matsushita M, et al : No association between the neuroleptic malignant syndrome and mutations in the RYR 1 gene associated malignant hyperthermia. J Neurol Sci 143 : 161-165, 1996
12. Keck PE Jr, Caroff SN, McElroy SL : Neuroleptic malignant syndrome and malignant hyperthermia : end of a controversy?. J Neuropsychiatry Clin Neurosci 7 : 135-144, 1995